[Clinical trials of cefmetazole on the bacterial infections of the skin (author's transl)]. 1981

T Matsumoto

Cefmetazole (CMZ) was applied to the subjects with infectious skin disease of more than middle severe cases in the present study, and the following results were obtained. 1. The clinical effects were as follows: among 15 clinical cases, 1 remarkably effective and 14 effective cases were observed, with 100% of effectiveness. 2. Bacteriological effects were as follows: 11 strains of S. aureus and 4 strains of S. epidermidis were isolated and all of them disappeared by the administration of CMZ. 3. Sensitivity test using a disc method showed that good sensitivity of better than (++) was obtained by CMZ and CEZ for all tested bacteria. 4. CMZ showed excellent clinical effects on the subjects to which oral cephalosporins and penicillins were not effective. 5. No undesirable side effects ascribable to the CMZ administration were observed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Matsumoto
November 1980, The Japanese journal of antibiotics,
T Matsumoto
March 1979, The Japanese journal of antibiotics,
T Matsumoto
May 1979, The Japanese journal of antibiotics,
T Matsumoto
March 1979, Tijdschrift voor diergeneeskunde,
T Matsumoto
April 1979, The Japanese journal of antibiotics,
T Matsumoto
April 1977, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!